These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18705238)

  • 1. Relationship between mixed chimerism and rejection after bone marrow transplantation in thalassaemia.
    Andreani M; Testi M; Battarra M; Indigeno P; Guagnano A; Polchi P; Federici G; Lucarelli G
    Blood Transfus; 2008 Jul; 6(3):143-9. PubMed ID: 18705238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience.
    Ball LM; Lankester AC; Giordano PC; van Weel MH; Harteveld CL; Bredius RG; Smiers FJ; Egeler RM; Vossen JM
    Bone Marrow Transplant; 2003 Jun; 31(12):1081-7. PubMed ID: 12796787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
    Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Cirocco R; Zucker K; Ciancio G; Burke G; Roth D; Temple D; Fuller L; Esquenazi V; Eskind L; Kenyon NS; Ricordi C; Tzakis A; Miller J
    Transplantation; 1998 Apr; 65(7):956-65. PubMed ID: 9565101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA.
    Mackinnon S; Barnett L; Bourhis JH; Black P; Heller G; O'Reilly RJ
    Blood; 1992 Dec; 80(12):3235-41. PubMed ID: 1467526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A more immunosuppressive pre-transplant conditioning may be required for Chinese patients with thalassaemia.
    Shing MM; Yuen PM; Li CK; Chik KW; Lai HD; Tsang KS; Ng MH; Tsoi WC
    Bone Marrow Transplant; 1996 Jun; 17(6):907-10. PubMed ID: 8807092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation.
    Kraus AB; Shaffer J; Toh HC; Preffer F; Dombkowski D; Saidman S; Colby C; George R; McAfee S; Sackstein R; Dey B; Spitzer TR; Sykes M
    Exp Hematol; 2003 Jul; 31(7):609-21. PubMed ID: 12842706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second marrow transplants for graft failure in patients with thalassemia.
    Gaziev D; Polchi P; Lucarelli G; Galimberti M; Sodani P; Angelucci E; Giardini C; Baronciani D; Erer B
    Bone Marrow Transplant; 1999 Dec; 24(12):1299-306. PubMed ID: 10627638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of beta-globin mutations shows stable mixed chimerism in patients with thalassemia after bone marrow transplantation.
    Kapelushnik J; Or R; Filon D; Nagler A; Cividalli G; Aker M; Naparstek E; Slavin S; Oppenheim A
    Blood; 1995 Oct; 86(8):3241-6. PubMed ID: 7579421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia.
    Andreani M; Manna M; Lucarelli G; Tonucci P; Agostinelli F; Ripalti M; Rapa S; Talevi N; Galimberti M; Nesci S
    Blood; 1996 Apr; 87(8):3494-9. PubMed ID: 8605369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of donor lymphocyte infusions in thalassemia patients at imminent risk of graft rejection following stem cell transplantation.
    Karasu GT; Yesilipek MA; Karauzum SB; Uygun V; Manguoglu E; Kupesiz A; Hazar V
    Pediatr Blood Cancer; 2012 Mar; 58(3):453-8. PubMed ID: 21990066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease.
    Hill RS; Petersen FB; Storb R; Appelbaum FR; Doney K; Dahlberg S; Ramberg R; Thomas ED
    Blood; 1986 Mar; 67(3):811-6. PubMed ID: 3511988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed donor chimerism in non-malignant haematological diseases after allogeneic bone marrow transplantation.
    Shamshad GU; Ahmed S; Bhatti FA; Ali N
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):765-8. PubMed ID: 23217481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
    Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
    Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparate lympho-erythroid donor to recipient chimaerism in a beta(0)-thalassaemia bone marrow transplant recipient with red cell indices indicative of apparent full engraftment.
    Weinberg RS; Vlachos A; Najfeld V; Galperin Y; Scalise A; Fruchtman S; Lipton JM
    Br J Haematol; 1997 Oct; 99(1):61-3. PubMed ID: 9359504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Radiation Dose and Low Cell Dose Increase the Risk of Graft Rejection in a Canine Hematopoietic Stem Cell Transplantation Model.
    Lange S; Steder A; Glass Ä; Killian D; Wittmann S; Machka C; Werner J; Schäfer S; Roolf C; Junghanss C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):637-643. PubMed ID: 26802322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer.
    Ringdén O; Söderdahl G; Mattsson J; Uzunel M; Remberger M; Hentschke P; Hägglund H; Sparrelid E; Elmhorn-Rosenborg A; Duraj F; Zetterquist H; Ericzon BG
    Transplantation; 2000 May; 69(10):2043-8. PubMed ID: 10852594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of bone marrow engraftment by amplification of hypervariable DNA regions.
    Martinelli G; Trabetti E; Farabegoli P; Testoni N; Bandini G; Motta MR; Vittone A; Terragna C; Pignatti PF; Tura S
    Haematologica; 1997; 82(2):156-60. PubMed ID: 9175318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
    Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.